Back to search

Peptide record

TPDB92064

LyeTxI-b Antibacterial Anticancer Toxicity standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB92064
LyeTxI-b
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia CancerPPD 2.0
standard
No
A 24-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3, Peptipedia, and CancerPPD 2.0, with an available 3D structural model.
C-terminal: Amidation
Sequence
IWLTALKFLGKNLGKLAKQQLAKL-NH2
Physicochemical Analysis
C129H219N33O29
RDCEHMPSYV
L
2696.36
11.12
5
0
13
+5
-1.03
0.288
142.50
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
5500
203.98
4
Residue Composition
number
3
A
0
R
1
N
0
D
0
C
0
E
2
Q
2
G
0
H
1
I
7
L
5
K
0
M
1
F
0
P
0
S
1
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 3 R: 0 N: 1 D: 0 C: 0 E: 0 Q: 2 G: 2 H: 0 I: 1 L: 7 K: 5 M: 0 F: 1 P: 0 S: 0 T: 1 W: 1 Y: 0 V: 0
Chemical Descriptors
24
C129H219N33O29
2696.36
11.12
+5
-1.03
0.288
Amidation
L
Linear
Free
Antimicrobial and Anticancer
Synthetic
Evidence Records 3 records
Evidence 1 Activity

Activity

IC50
IC50 = 6.5 ± 5.30 µM
Anticancer
6.5

Target

Breast Cancer
4T1
Breast

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2021

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 7.34 ± 3.09 µM
Anticancer
7.34

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2021
Evidence 3 Activity

Activity

IC50
IC50 = 5.77 ± 0.83 µM
Anticancer
5.77

Target

Breast Cancer
MDA-MB-231
Breast

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2021